Bio Impact Capital LLC Rocket Pharmaceuticals, Inc. Transaction History
Bio Impact Capital LLC
- $552 Million
- Q3 2025
A detailed history of Bio Impact Capital LLC transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Bio Impact Capital LLC holds 3,903,381 shares of RCKT stock, worth $11.9 Million. This represents 2.3% of its overall portfolio holdings.
Number of Shares
3,903,381
Previous 3,903,081
0.01%
Holding current value
$11.9 Million
Previous $9.56 Million
33.08%
% of portfolio
2.3%
Previous 1.87%
Shares
5 transactions
Others Institutions Holding RCKT
# of Institutions
195Shares Held
96.5MCall Options Held
563KPut Options Held
418K-
Rtw Investments, LP New York, NY17.7MShares$53.9 Million0.77% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.47MShares$25.8 Million0.41% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.89MShares$21 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$18.9 Million0.0% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.84MShares$11.7 Million0.38% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $231M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...